RESCORCINOLS, METHODS FOR THEIR MANUFACTURE, AND USES THEREOF
The present invention relates to a group of resorcinol derivatives as a pharmaceutically active compounds and methods of preparation thereof. Resorcinol derivatives have been used to treat various diseases and disorders. While such treatments hold promise, there remains a need in the art for more effective treatments and this has been brought about by way of the resorcinol derivative of the invention..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Europäisches Patentamt - (2023) vom: 30. Nov. Zur Gesamtaufnahme - year:2023 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
SILCOCK ALAN JAMES [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-11-30, Last update posted on www.tib.eu: 2024-01-29, Last updated: 2024-02-02 |
---|
Patentnummer: |
AU2022275207 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA018713270 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | EPA018713270 | ||
003 | DE-627 | ||
005 | 20240202085249.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231215s2023 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA018713270 | ||
035 | |a (EPA)AU2022275207 | ||
035 | |a (EPA)81750790 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a SILCOCK ALAN JAMES |e verfasserin |4 aut | |
245 | 1 | 0 | |a RESCORCINOLS, METHODS FOR THEIR MANUFACTURE, AND USES THEREOF |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2023-11-30, Last update posted on www.tib.eu: 2024-01-29, Last updated: 2024-02-02 | ||
520 | |a The present invention relates to a group of resorcinol derivatives as a pharmaceutically active compounds and methods of preparation thereof. Resorcinol derivatives have been used to treat various diseases and disorders. While such treatments hold promise, there remains a need in the art for more effective treatments and this has been brought about by way of the resorcinol derivative of the invention. | ||
650 | 4 | |a C07D: Heterocyclic compounds (macromolecular compounds c08) | |
650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
650 | 4 | |a che | |
650 | 4 | |a C07C: Acyclic or carbocyclic compounds (macromolecular compounds c08;production of organic compounds by electrolysis or electrophoresis c25b0003000000, c25b0007000000) | |
650 | 4 | |a 615 | |
700 | 0 | |a TSE KAREN KA-YEN |4 aut | |
700 | 0 | |a HINCHLIFFE PAUL STUART |4 aut | |
700 | 0 | |a SHARPE ANDREW |4 aut | |
700 | 0 | |a SIMPSON IAIN DAVID |4 aut | |
700 | 0 | |a PEACH JOANNE |4 aut | |
700 | 0 | |a LEVANTO STEFANO |4 aut | |
700 | 0 | |a MILLET ANTOINE |4 aut | |
700 | 0 | |a MANN INDERJIT |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 30. Nov. |
773 | 1 | 8 | |g year:2023 |g day:30 |g month:11 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/81750790/publication/AU2022275207A1?q=AU2022275207 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
936 | u | w | |j 2023 |b 30 |c 11 |
951 | |a AR | ||
952 | |j 2023 |b 30 |c 11 |